The Surrey Heartlands Joint Formulary and Prescribing Advisory Database (PAD) is available here.
The platform and content have been developed in consultation and collaboration with system partners across Surrey Heartlands and replaces previous medicines formularies for Ashford and St Peters NHS Foundation Trust, Royal Surrey Hospital NHS Foundation Trust, Surrey and Sussex Healthcare NHS Trust and Surrey and Borders Partnership NHS Foundation Trust.
The formulary content is built on the decisions reached by the Surrey Heartlands Area Prescribing Committee (APC) and the Acute Trust Drugs and Therapeutic Committees and utilises the existing colour classification system (Traffic light status) used across Surrey Heartlands.
For FAQs on the Joint formulary go here: FAQs Joint Formulary
For instructions on how to use the new Joint Formulary go here: User Guide Joint Formulary
Medicines that are only prescribed in a hospital setting and will not be prescribed in primary care (i.e. hospital-only drugs where treatment is initiated and continued by specialist clinicians) are ratified by the SASH DTG. Medicines that may be prescribed in both the hospital setting and in primary care are ratified by the APC.
The Surrey Heartlands Joint Formulary and PAD contains links to shared care guidelines and updated NICE Technology Appraisals; newer agents are colour-coded in the Surrey Heartlands APC Traffic Light System to reflect where clinical prescribing responsibility lies for a specific medicine.
Only medicines ticked on the SASH section of the Surrey Heartlands Joint Formulary and PAD can be prescribed from within the Trust (i.e. inpatient and outpatient). Advice given to GPs regarding drug treatment options must also be in line with the SASH section of the Surrey Heartlands Joint Formulary and PAD.
For any feedback relating to the SASH section of the Surrey Heartlands Joint Formulary and PAD, please contact the Formulary Development Pharmacist: sash.